Colgate-Palmolive (NYSE:CL) SVP Sells $34,495.89 in Stock

Share on StockTwits

Colgate-Palmolive (NYSE:CL) SVP John J. Huston sold 473 shares of the business’s stock in a transaction on Monday, June 17th. The shares were sold at an average price of $72.93, for a total transaction of $34,495.89. Following the transaction, the senior vice president now owns 59,668 shares of the company’s stock, valued at $4,351,587.24. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

NYSE:CL traded up $0.64 during midday trading on Wednesday, hitting $73.53. The company had a trading volume of 2,406,364 shares, compared to its average volume of 3,603,452. Colgate-Palmolive has a 52-week low of $57.41 and a 52-week high of $74.14. The firm has a market capitalization of $63.02 billion, a PE ratio of 24.76, a price-to-earnings-growth ratio of 4.81 and a beta of 0.80. The company has a debt-to-equity ratio of 32.25, a quick ratio of 0.74 and a current ratio of 1.07.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, April 26th. The company reported $0.67 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.66 by $0.01. Colgate-Palmolive had a net margin of 15.08% and a negative return on equity of 3,730.37%. The company had revenue of $3.88 billion during the quarter, compared to analyst estimates of $3.86 billion. During the same period in the previous year, the business earned $0.74 earnings per share. The firm’s quarterly revenue was down 2.9% compared to the same quarter last year. On average, sell-side analysts forecast that Colgate-Palmolive will post 2.84 EPS for the current fiscal year.

A number of research firms have recently commented on CL. Wells Fargo & Co restated a “hold” rating and set a $68.00 price target (up from $65.00) on shares of Colgate-Palmolive in a research report on Monday. Argus boosted their price target on shares of Colgate-Palmolive from $72.00 to $82.00 and gave the company a “buy” rating in a research report on Tuesday, June 11th. Zacks Investment Research lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $77.00 price target for the company. in a research report on Friday, June 7th. ValuEngine upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Monday, May 13th. Finally, Macquarie boosted their price target on shares of Colgate-Palmolive from $65.00 to $72.00 and gave the company a “neutral” rating in a research report on Monday, April 29th. One analyst has rated the stock with a sell rating, twelve have issued a hold rating and five have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $70.87.

Large investors have recently made changes to their positions in the stock. Vanguard Group Inc raised its position in shares of Colgate-Palmolive by 1.0% in the third quarter. Vanguard Group Inc now owns 73,520,894 shares of the company’s stock valued at $4,922,224,000 after buying an additional 734,860 shares during the last quarter. Victory Capital Management Inc. raised its position in shares of Colgate-Palmolive by 5.1% in the fourth quarter. Victory Capital Management Inc. now owns 315,759 shares of the company’s stock valued at $18,794,000 after buying an additional 15,205 shares during the last quarter. Portfolio Solutions LLC acquired a new stake in shares of Colgate-Palmolive in the fourth quarter valued at about $30,000. Commerzbank Aktiengesellschaft FI raised its position in shares of Colgate-Palmolive by 33.6% in the fourth quarter. Commerzbank Aktiengesellschaft FI now owns 274,460 shares of the company’s stock valued at $16,336,000 after buying an additional 69,093 shares during the last quarter. Finally, Cerity Partners LLC raised its position in shares of Colgate-Palmolive by 3.7% in the fourth quarter. Cerity Partners LLC now owns 5,466 shares of the company’s stock valued at $325,000 after buying an additional 197 shares during the last quarter. Institutional investors own 75.60% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This news story was originally reported by Ticker Report and is owned by of Ticker Report. If you are accessing this news story on another website, it was copied illegally and republished in violation of US and international trademark and copyright legislation. The original version of this news story can be accessed at https://www.tickerreport.com/banking-finance/4380033/colgate-palmolive-nysecl-svp-sells-34495-89-in-stock.html.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Featured Article: Why is the ROA ratio important?

Insider Buying and Selling by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

MKM Partners Lowers ADTRAN  Price Target to $17.00
MKM Partners Lowers ADTRAN Price Target to $17.00
Apple  PT Raised to $180.00 at Nomura
Apple PT Raised to $180.00 at Nomura
Advaxis  Lowered to “Hold” at ValuEngine
Advaxis Lowered to “Hold” at ValuEngine
Zacks Investment Research Upgrades Atlas Air Worldwide  to “Hold”
Zacks Investment Research Upgrades Atlas Air Worldwide to “Hold”
Apple  Raised to “Outperform” at Raymond James
Apple Raised to “Outperform” at Raymond James
Zacks Investment Research Lowers Agilysys  to Hold
Zacks Investment Research Lowers Agilysys to Hold


© 2006-2019 Ticker Report